Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Pap Smears Maintaining Execellence With Understanding Objectives • • • • • Review historical evolution Explain new guidelines for paps Discuss sampling techniques Interpreting results Deliver information to clients Cervical Cancer • • • • • • • • Not recognized until C16 1700s Bernardino Ramazzini Professor of Medicine University of Modena & Padua De Morbis Artificium Diatriba –Described cervical cancer –Absence of disease in nuns Cervical Cancer Late C19 • Early onset sexual activity • Multiple partners • Association with other STD George Papanicolaou George Papanicolaou • • • • • • •Greek Physician •Immigrated to USA •Research – hormones in guinea pigs •Swabbed cervix- distinct cells •Performed same on wife •1925 chance encounter volunteers showed signs of cancer • •Screening test delayed 30 years • •1954 Atlas of Exfoliative Cytology Impact of Screening Cancer of the Cervix (mortality/100,000) Where are we failing Globally? • While mortality is falling in the developed world • Mortality is rising in the developing world Estimated numbers of new cases & deaths from cervical cancer by Province in Canada 2002 Newfoundland/Labrador Prince Edward Island Nova Scotia New Brunswick Quebec Ontario Manitoba Saskatchewan Alberta British Columbia Total for Canada New Cases 25 10 55 35 280 510 45 45 170 160 1350 Deaths 15 5 20 10 75 150 15 15 40 50 390 Cervical Cancer—Cause? • • • • Cervical Cancer Cause? •Herpes simplex virus •Major player •Observation: 50% women with cervical cancer had HSV 2 • •Women with HSV antibodies 10x more likely to develop cervical cancer • 1973 International Conference • on Herpes virus and Cervical Cancer Association ≠ Causation HPV? Harald zur Hausen •Relationship between condyloma & genital cancer •Isolated HPV 6 & 11 in genital warts 1983, zur Hausen’s Lab •Identified HPV 16 &18 •Cervical cancer biopsies HPV Types in Benign & Malignant Lesions • • • • • LESION PROMINENT HPV TYPE Skin warts plantar warts --------------------------- 1 common wart -------------------------- 2,27 flat wart ---------------------------------- 3,10,28,41 • Anogenital lesions • condyloma acuminata ---------------- 6,11 • cervical, vulvar intraepithelial neo- 6,11,16,18,31 HPV Types in Benign & Malignant Lesions LESION PROMINENT TYPE • Benign head & neck lesions • oral papilloma --------------------- 2,6,11,16 • laryngeal papilloma -------------- 6,11 • • • • • Malignancies cervical cancer -------------------- 16,18,31,35 other anogenital cancers ------- 6,16,18 oral cancer ------------------------- 3,6,11,16,18,57 esophageal cancer --------------- 6,11,16,18 HPV • • • • •Most common STI •Infects 550,000 Canadians annually •Most transmit from skin to skin contact •Most infections go unnoticed and resolve spontaneously within 24 months • •Persistent infection with HPV 16 or 18 can lead to cervical cancer HPV Epidemiology •Majority of sexually active adults have genital HPV infection at some time in their life •Most infections are transient and resolve spontaneously within 24 months Cervical Cell Maturation Mature Squamous layer Squamous Suprabasalar layer Parabasal cells Parabasal cells Sampling • What is required for an adequate specimen? --Columnar Cells --Squamous Cell -- SCJ (squamocolumnar junction) New Guidelines Clear as mud! . Rational: The high rate of spontaneous regression of dysplastic changes annual screening results in unnecessary colposcopic examination and treatment with annual screening Plan: phased approach to cervical correspondence to women similar to breast and colorectal screening programs Cervical Screening Program: 2012 Guidelines • Clarify the start and stop age for cervical screening • Identify the optimum interval for screening • Identify the exceptions Cancer Care Ontario (CCO) Cervical Screening Guidelines Initiation (When to begin obtaining Pap tests) Age 21 if sexually active If not sexually active by age 21, delay until sexually active Interval (Frequency of Pap Tests) Every 3 years Cessation (When to stop obtaining Pap tests) Age 70 if 3 or more negative tests in past 10 years Notification of Women Cancer Care Ontario Timeline • •August 2013: privacy notices mailing begins • •September 2013: results letters of Paps done since July 1, 2013 mailing begins • •October 2013: 30-69 need q3yr screening privacy notification & invitation • •November 2013: 30-69 invited for their first screen • Lead Scientist Ontario Cervical Screening Program Cancer Care Ontario CCO New Guidelines • •“Although HPV testing is the preferred screening test for cervical cancer and remains a goal, we continue to recommend cytology as the primary screen tool.” (CCO) • The absence of T-zone is not a reason to shorten the screening interval Current Protocol The Ideal World---$ 90.00 Abnormal result following inappropriate screening: ? Follow-up • Juvavunski Hospital –Refuse referrals in women ˂ 21, unless high grade • CCO –Abnormal paps should be managed according to protocol regardless of the appropriateness of the screening Follow-up following discharge from colposcopy • •If treated for high grade – perform annual pap smears • •If no treatment – perform to q-3-year screens after 3 negative paps • Based on cessation of screening • at age 70→ 3 normal smears in • 10 years??? What about the woman who still wants an annual pap? • •Explain the rational behind 3 year screening • –Annual screening results in more abnormal paps • –Most abnormalities will resolve spontaneously • –Acting on abnormal papas results in interventions that are not risk free • •$ is not just that of the pap provider • –The lab will not get paid and they will go after the patient The Pelvic Exam Equipment • • • • • Proper lighting Gloves Speculum (range of sizes) Sampling equipment for Paps and cultures Have two of everything to avoid having to avoid delays • Draping material (often paper) Exam Environment • • • • • Comfortable room temperature Foot of the table away from the door Windows covered Ideally elevate head of table Privacy and confidentiality Pap Smear Liquid Based Cytology Speculum Insertion I can not find the Cervix! • •Relax, take a deep breath • •Unless she forgot to tell you about her hysterectomy, it is there. • •Avoid diving in and out with the speculum and think about the anatomy • Ask the patient to make a fist with both hands and push them under her hips, fingers down Condom or large glove finger can help if Vaginal walls obscure cervix Informing the Patient/Client of Abnormal Pap Results • Begin layering in education and understanding at the time of the history/examination • “Paps are a screening tool not a diagnostic tool • Share any findings with her • Use language like—”healthy”, “wellestorgenized “, “natural changes” • Do not use “normal” or “abnormal” Further to Informing the Patient • Empower her throughout the appt. to ask questions and make informed choices. • Help her understand that dyspasia is not cancer, but will be referred to as “precancer”meaning “has the potential”. • Reduce the fear that a pap smear that is not negative…is positive for cancer What is ASCUS? • Abnormal Squamous Cells of Undetermined Significance!!! What? • It is important to compare this finding with the clinical findings • The Bethesda Cervical Screening –gives us and understanding of the cells that are assessed as “not normal” but not dysplastic---ie ASCUS favouring atropic changes. Colposcopy Referrals • Prepare that patient for the assessment, defuse the anxiety if you can • The pelvic exam is enhanced by fiberoptic lighting and magnafication. • Acidic acid 5% (vineger) is used to bathe the cervix and highlight the abnormal patches on the cervix. • A biopsy may be taken to diagnose the abnormality, following the abnormal pap. Colposcopy • Prepare her for the fact that the referral will involve several visits, including initial assessment, treatment (if necessary) and follow up visits to insure the cervical cells have returned to normal. Summary • Clear patient education and communication • Empower the patient • Respect and accommodate, cultural and physical restrictions. • Be the patient advocate at all times. • Questions?